Kamada Ltd.

KMDA ·Healthcare, Drug Manufacturers - General, Israel
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015
Operating Activities
Net Income $6.9M $-6.7M $-11.3M
Depreciation & Amortization — — —
Depreciation — — —
Amortization — — —
Stock-Based Compensation $483.0K $1.1M $1.9M
Net Cash from Operating Activities $3.6M $1.9M $-14.0M
Investing Activities
Capital Expenditures $4.2M $2.6M $2.7M
Business Acquisitions — — —
Net Cash from Investing Activities $-15.6M $1.6M $11.3M
Financing Activities
Dividends Paid — — —
Stock Repurchases — — —
Net Cash from Financing Activities $15.3M $1.5M $-6.4M
Net Change in Cash $2.7M $4.9M $-9.5M
Free Cash Flow $-559.0K $-744.0K $-16.7M
← Newer Page 2 of 2 Older →